Triple-negative Thrombocythemia and Subsequent Acute Lymphoblastic Leukemia with Additional Somatic Mutations-Reference-Cited by-同舟云学术

Triple-negative Thrombocythemia and Subsequent Acute Lymphoblastic Leukemia with Additional Somatic Mutations

Published:2022 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tsuboi Yuri¹,Sakamoto Tatsuhiro¹,Makishima Kenichi²,Suehara Yasuhito¹,Hattori Keiichiro³,Kurita Naoki¹,Yokoyama Yasuhisa¹,Kato Takayasu¹,Nishikii Hidekazu¹,Obara Naoshi¹,Matsumura Fumiaki¹,Matsuoka Ryota⁴,Chiba Shigeru³,Sakata-Yanagimoto Mamiko¹

Affiliation:

1. Department of Hematology, University of Tsukuba Hospital, Japan

2. Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan

3. Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan

4. Department of Pathology, Faculty of Medicine, University of Tsukuba, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_0269-22/_pdf

Reference16 articles.

1. 1. Swerdllow S, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2017.

2. 2. Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv 5 (4): 1059-1068, 2021, DOI: 10.1182/bloodadvances.2020003172

3. 3. Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 5: e366, 2015, DOI: 10.1038/bcj.2015.95

4. 4. Hashimoto Y, Ito T, Gotoh A, et al. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study. Int J Hematol 115 (2): 208-221, 2022, DOI: 10.1007/s12185-021-03253-0

5. 5. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 81 (2): 159-166, 2006, DOI: 10.4065/81.2.159